ABIOMED Inc (NASDAQ:ABMD) over-valued by 10%
| Website | http://www.abiomed.com/ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Mar 31, 2021 |
| Market Cap | $12,403,321,856 |
| Beta | 1.309983 |
| Average Volume | $282,077 |
| Last Dividend | 0% |
| Price on Feb 3, 2022 | $325.42 |
| Autochartist™ Valuation | $292.64 |
| Conclusion |
10% over-valued |
| Download Report |
